Michael Laposata has been awarded the 2025 Champion for Innovation Award by the Association for Molecular Pathology (AMP) for his extensive contributions to laboratory medicine and his pivotal role in challenging FDA regulations on laboratory-developed tests (LDTs). This award, presented during AMP's annual meeting in Boston, acknowledges Laposata's commitment to enhancing clinical laboratory practices, which has helped safeguard diagnostic innovation and maintain patient access to essential services. His impressive career spans over 30 years, including roles as a professor and author of influential medical literature.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
